Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalised Pharmacometabolomic-guided Strategy Trial to Optimise Treatment for Hypertension (HYPERMARKER)

NCT07294794 is registered in ClinicalTrials.gov with University of Birmingham as lead sponsor.

NCT NCT07294794
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07294794 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalised Pharmacometabolomic-guided Strategy Trial to Optimise Treatment for Hypertension (HYPERMARKER)
Lead sponsor
University of Birmingham
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 19, 2026
Completion date
December 31, 2026
Enrollment
400 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension